<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">29451958</PMID>
      <DateCompleted>
        <Year>2018</Year>
        <Month>08</Month>
        <Day>31</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>01</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1932-8737</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>41</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2018</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical cardiology</Title>
          <ISOAbbreviation>Clin Cardiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Peripartum cardiomyopathy: Status 2018.</ArticleTitle>
        <Pagination>
          <StartPage>217</StartPage>
          <EndPage>219</EndPage>
          <MedlinePgn>217-219</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/clc.22888</ELocationID>
        <Abstract>
          <AbstractText>Peripartum cardiomyopathy is a rare cardiac condition, overall. However, in certain populations can be found frequently enough and the signs, symptoms, and management should be readily understood. Here we provide an updated overview of this topic.</AbstractText>
          <CopyrightInformation>© 2018 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gupta</LastName>
            <ForeName>Divya</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Emory University Hospital, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wenger</LastName>
            <ForeName>Nanette K</ForeName>
            <Initials>NK</Initials>
            <Identifier Source="ORCID">0000-0002-6503-9139</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Emory University School of Medicine, Grady Memorial Hospital, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>02</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Clin Cardiol</MedlineTA>
        <NlmUniqueID>7903272</NlmUniqueID>
        <ISSNLinking>0160-9289</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058725" MajorTopicYN="Y">Peripartum Period</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011249" MajorTopicYN="Y">Pregnancy Complications, Cardiovascular</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cardiomyopathy</Keyword>
        <Keyword MajorTopicYN="N">Peripartum</Keyword>
        <Keyword MajorTopicYN="N">outcomes</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no potential conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>1</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29451958</ArticleId>
        <ArticleId IdType="pmc">PMC6490057</ArticleId>
        <ArticleId IdType="doi">10.1002/clc.22888</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA.
2000;283:1183–1188.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10703781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sliwa K, Hilfiker‐Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail.
2010;12:767–778.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20675664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Demakis JG, Rahimtoola SH. Peripartum cardiomyopathy. Circulation.
1971;44:964–968.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4255967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Johnson‐Coyle L, Jensen L, Sobey A, American College of Cardiology Foundation; American Heart Association. Peripartum cardiomyopathy: review and practice guidelines. Am J Crit Care.
2012;21:89–98.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22381985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tidswell M. Peripartum cardiomyopathy. Crit Care Clin.
2004;20:777–788, xi.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15388202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO‐1. J Am Coll Cardiol.
2000;35:701–705.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10716473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kamiya CA, Kitakaze M, Ishibashi‐Ueda H, et al. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. ‐Results from the Japanese Nationwide survey of peripartum cardiomyopathy. Circ J.
2011;75:1975–1981.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21617320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Capriola M. Peripartum cardiomyopathy: a review. Int J Womens Health.
2013;5:1–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3536353</ArticleId>
            <ArticleId IdType="pubmed">23300351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Isezuo SA, Abubakar SA. Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethn Dis.
2007;17:228–233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17682350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sliwa K, Mebazaa A, Hilfiker‐Kleiner D, et al. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM. Eur J Heart Fail.
2017;19:1131–1141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28271625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Elkayam U, Akhter MW, Singh H, et al. Pregnancy‐associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation.
2005;111:2050–2055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15851613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gunderson EP, Croen LA, Chiang V, Yoshida CK, Walton D, Go AS. Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol.
2011;118:583–591.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21860287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hilfiker‐Kleiner D, Haghikia A, Nonhoff J, Bauersachs J. Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J.
2015;36:1090–1097.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4422973</ArticleId>
            <ArticleId IdType="pubmed">25636745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ansari AA, Fett JD, Carraway RE, Mayne AE, Onlamoon N, Sundstrom JB. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol.
2002;23:301–324.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12402414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lapaire O, Hosli I, Zanetti‐Daellenbach R, et al. Impact of fetal‐maternal microchimerism on women's health—a review. J Matern Fetal Neonatal Med.
2007;20:1–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17437192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Patten IS, Rana S, Shahul S, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature.
2012;485:333–338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3356917</ArticleId>
            <ArticleId IdType="pubmed">22596155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol.
2009;53:e1–e90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19358937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lata I, Gupta R, Sahu S, Singh H. Emergency management of decompensated peripartum cardiomyopathy. J Emerg Trauma Shock.
2009;2:124–128.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2700591</ArticleId>
            <ArticleId IdType="pubmed">19561973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bhattacharyya A, Basra SS, Sen P, Kar B. Peripartum cardiomyopathy: a review. Tex Heart Inst J.
2012;39:8–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3298938</ArticleId>
            <ArticleId IdType="pubmed">22412221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hilfiker‐Kleiner D, Haghikia A, Berliner D, et al. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J.
2017;38:2671–2679.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5837241</ArticleId>
            <ArticleId IdType="pubmed">28934837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Safirstein JG, Ro AS, Grandhi S, Wang L, Fett JD, Staniloae C. Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int J Cardiol.
2012;154:27–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20863583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Heart Failure Society of America
. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail.
2006;12:10–38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16500578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Brar SS, Khan SS, Sandhu GK, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol.
2007;100:302–304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17631087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cooper LT, Mather PJ, Alexis JD, et al. Myocardial recovery in peripartum cardiomyopathy: prospective comparison with recent onset cardiomyopathy in men and nonperipartum women. J Card Fail.
2012;18:28–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3421073</ArticleId>
            <ArticleId IdType="pubmed">22196838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Biteker M, Ilhan E, Biteker G, Duman D, Bozkurt B. Delayed recovery in peripartum cardiomyopathy: an indication for long‐term follow‐up and sustained therapy. Eur J Heart Fail.
2012;14:895–901.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22588321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hilfiker‐Kleiner D, Haghikia A, Masuko D, et al. Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy. Eur J Heart Fail.
2017;19:1723–1728.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28345302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Halkein J, Tabruyn SP, Ricke‐Hoch M, et al. MicroRNA‐146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest.
2013;123:2143–2154.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3638905</ArticleId>
            <ArticleId IdType="pubmed">23619365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Dorbala S, Brozena S, Zeb S, et al. Risk stratification of women with peripartum cardiomyopathy at initial presentation: a dobutamine stress echocardiography study. J Am Soc Echocardiogr.
2005;18:45–48
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15637488</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
